{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:16:46Z","timestamp":1783689406214,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58327-y","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:26:19Z","timestamp":1743017179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China"],"prefix":"10.1038","volume":"16","author":[{"given":"Siyue","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-0864","authenticated-orcid":false,"given":"Zhenglun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-0006","authenticated-orcid":false,"given":"Fengcai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-5151","authenticated-orcid":false,"given":"Jingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"58327_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41577-022-00771-8","volume":"22","author":"R Suryawanshi","year":"2022","unstructured":"Suryawanshi, R. & Ott, M. SARS-CoV-2 hybrid immunity: silver bullet or silver lining? Nat. Rev. Immunol. 22, 591\u2013592 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"58327_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36250-4","volume":"14","author":"J Pu\u0161nik","year":"2023","unstructured":"Pu\u0161nik, J. et al. SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection. Nat. Commun. 14, 572 (2023).","journal-title":"Nat. Commun."},{"key":"58327_CR3","unstructured":"World Health Organization. Statement on the antigen composition of COVID-19 vaccines. https:\/\/www.who.int\/news\/item\/18-05-2023-statement-on-the-antigen-composition-of-covid-19-vaccines (2023)."},{"key":"58327_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2023.102364","volume":"66","author":"Z Ba","year":"2024","unstructured":"Ba, Z. et al. Vaccine inequity-induced COVID-19 dilemma: time to sober up. Leg. Med. (Tokyo) 66, 102364 (2024).","journal-title":"Leg. Med. (Tokyo)"},{"key":"58327_CR5","doi-asserted-by":"publisher","unstructured":"Privor-Dumm, L. et al. Vaccine access, equity and justice: COVID-19 vaccines and vaccination. BMJ Glob. Health 8, https:\/\/doi.org\/10.1136\/bmjgh-2023-011881 (2023).","DOI":"10.1136\/bmjgh-2023-011881"},{"key":"58327_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13906","volume":"53","author":"S Pilz","year":"2023","unstructured":"Pilz, S. & Ioannidis, J. P. A. Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS-CoV-2 in the endemic phase? Eur. J. Clin. Investig. 53, e13906 (2023).","journal-title":"Eur. J. Clin. Investig."},{"key":"58327_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2191738","volume":"12","author":"L Zheng","year":"2023","unstructured":"Zheng, L., Liu, S. & Lu, F. Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China. Emerg. Microbes Infect. 12, 2191738 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"58327_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2332660","volume":"13","author":"S Jia","year":"2024","unstructured":"Jia, S. et al. Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study. Emerg. Microbes Infect. 13, 2332660 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"58327_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.46234\/ccdcw2023.070","volume":"5","author":"D Fu","year":"2023","unstructured":"Fu, D. et al. Effectiveness of COVID-19 vaccination against SARS-CoV-2 omicron variant infection and symptoms\u2014China, December 2022\u2013February 2023. China CDC Wkly 5, 369\u2013373 (2023).","journal-title":"China CDC Wkly"},{"key":"58327_CR10","doi-asserted-by":"publisher","unstructured":"Bates, T. A. et al. An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants. JCI Insight 8, https:\/\/doi.org\/10.1172\/jci.insight.165265 (2023).","DOI":"10.1172\/jci.insight.165265"},{"key":"58327_CR11","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/cid\/ciac327","volume":"75","author":"NK Shrestha","year":"2022","unstructured":"Shrestha, N. K. et al. Coronavirus disease 2019 vaccine boosting in previously infected or vaccinated individuals. Clin. Infect. Dis. 75, 2169\u20132177 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"58327_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","volume":"386","author":"V Hall","year":"2022","unstructured":"Hall, V. et al. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection. N. Engl. J. Med. 386, 1207\u20131220 (2022).","journal-title":"N. Engl. J. Med."},{"key":"58327_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239179","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients. Front. Immunol. 14, 1239179 (2023).","journal-title":"Front. Immunol."},{"key":"58327_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S2213-2600(23)00049-8","volume":"11","author":"R Tang","year":"2023","unstructured":"Tang, R. et al. Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial. Lancet Respir. Med. 11, 613\u2013623 (2023).","journal-title":"Lancet Respir. Med."},{"key":"58327_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2281355","volume":"13","author":"JW Xu","year":"2024","unstructured":"Xu, J. W. et al. Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial. Emerg. Microbes Infect. 13, 2281355 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"58327_CR16","unstructured":"World Health Organization. COVID-19 advice for the public: Getting vaccinated. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines\/advice (2023)."},{"key":"58327_CR17","doi-asserted-by":"publisher","unstructured":"Spinardi, J. R. & Srivastava, A. Hybrid immunity to SARS-CoV-2 from infection and vaccination\u2014evidence synthesis and implications for new COVID-19 vaccines. Biomedicines 11, https:\/\/doi.org\/10.3390\/biomedicines11020370 (2023).","DOI":"10.3390\/biomedicines11020370"},{"key":"58327_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","volume":"23","author":"N Bobrovitz","year":"2023","unstructured":"Bobrovitz, N. et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect. Dis. 23, 556\u2013567 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"58327_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1273745","volume":"11","author":"W Zhu","year":"2023","unstructured":"Zhu, W. et al. Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China. Front. Public Health 11, 1273745 (2023).","journal-title":"Front. Public Health"},{"key":"58327_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1319","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection. Clin. Transl. Immunol. 10, e1319 (2021).","journal-title":"Clin. Transl. Immunol."},{"key":"58327_CR21","unstructured":"European Commission. Union Register of medicinal products for human use. https:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/h1528.htm (2024)."},{"key":"58327_CR22","unstructured":"U.S. Food and Drug Administration. FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-updated-novavax-covid-19-vaccine-formulated-better-protect-against-currently (2023)."},{"key":"58327_CR23","unstructured":"World Health Organization. Statement on the antigen composition of COVID-19 vaccines. https:\/\/www.who.int\/news\/item\/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines (2024)."},{"key":"58327_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/14760584.2024.2346589","volume":"23","author":"T Ulrichs","year":"2024","unstructured":"Ulrichs, T. et al. Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies. Expert Rev. Vaccines 23, 510\u2013522 (2024).","journal-title":"Expert Rev. Vaccines"},{"key":"58327_CR25","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice on the Diagnosis and Treatment Protocol for SARS-CoV-2 Infection (Trial Version 10). http:\/\/www.nhc.gov.cn\/xcs\/zhengcwj\/202301\/32de5b2ff9bf4eaa88e75bdf7223a65a.shtml (2023)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58327-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T02:37:36Z","timestamp":1743043056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58327-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58327"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58327-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2969"}}